Technology & Medicine › Internet, genomes & AI
mRNA vaccines
December 2020 (COVID-19 vaccines)· Invention or discovery· Germs, drugs & genetics
Well documentedSolid records, physical evidence or scientific consensus.
Vaccines that deliver genetic instructions so the body's own cells make a harmless piece of a virus, training immunity.
See it on the Technology & Medicine map →How it works
An mRNA vaccine delivers a genetic instruction, wrapped in a tiny fat bubble (lipid nanoparticle), telling cells to make one harmless virus protein; for COVID-19, the 'spike'. The immune system learns to recognize it. The mRNA breaks down within days and does not alter DNA. Pfizer–BioNTech's vaccine was authorized in Britain on December 2, 2020, and Moderna's in the US on December 18; trials showed about 95% protection against symptomatic illness.
Why it mattered
They went from virus sequence to authorized vaccine in under a year, a record, and the platform is now used or tested against RSV, flu and cancers.
Think of it like
Like emailing building security a photo of a known trespasser: the photo is deleted, but the guards remember the face.
How we know
Phase 3 trials of over 70,000 volunteers, published in late 2020; regulators' authorization records; real-world studies estimating that COVID-19 vaccines averted millions of deaths.
Still unknown or debated
Why protection against infection fades within months while protection against severe disease lasts longer is still studied, as are rare cases of heart inflammation.
Inside this (2)
Connections (4)
▸Vaccination (Jenner's smallpox vaccine) was reinvented, 224 years on, as mRNA vaccinesWell documented
The connection
Jenner's smallpox vaccine and mRNA vaccines share one principle: show the immune system a harmless version of a threat so it remembers. Jenner used cowpox; later vaccines used weakened or killed germs or purified proteins. mRNA vaccines instead give cells instructions to make the warning protein themselves, so they can be designed quickly from a genetic sequence.
When and how
Jenner in Berkeley, England, May 1796; BioNTech in Mainz, Germany, with Pfizer, and Moderna in Cambridge, Massachusetts, 2020.
How we know
The shared immune-memory principle is established immunology; the 224 years run from Jenner's 1796 test to the first mRNA vaccine authorization in December 2020.
Debates and open questions
Whether mRNA will replace traditional vaccines or stay one option among many is open; some older vaccines, such as measles, give longer-lasting protection.
▸Karikó and Weissman's modified mRNA made possible mRNA vaccinesWell documented
The connection
Unmodified mRNA alarmed the immune system, causing inflammation and producing little protein. Karikó and Weissman's swap of uridine for a modified version solved that. Both the Pfizer–BioNTech and Moderna COVID-19 vaccines use a related building block, N1-methylpseudouridine, packed in lipid nanoparticles. Karikó had joined BioNTech in 2013, helping carry the method into its vaccine.
When and how
University of Pennsylvania, 2005 and 2008 papers; licensed onward to BioNTech in Mainz and Moderna in Massachusetts; vaccines authorized December 2020.
How we know
Vaccine ingredient lists show the modified building block; the 2023 Nobel citation credits the discovery with enabling effective mRNA vaccines against COVID-19.
Debates and open questions
CureVac's unmodified-mRNA COVID-19 vaccine managed only about 48% efficacy in 2021, supporting the modification's importance, though dose differences complicate the comparison.
▸COVID-19 pandemic was met in under a year by mRNA vaccinesWell documented
The connection
Chinese scientists posted the virus's genome on January 10–11, 2020. Moderna finalized its vaccine design within about two days, and BioNTech launched 'Project Lightspeed' within weeks. With heavy government funding such as the US Operation Warp Speed, overlapping trial phases and manufacturing at risk, the first authorization came on December 2, 2020, about 11 months later.
When and how
A Shanghai team led by Zhang Yongzhen shared the sequence; BioNTech in Mainz with Pfizer, Moderna with the US National Institutes of Health; Britain authorized first.
How we know
Trial publications, company timelines and regulators' records document each step, from sequence release to emergency authorization in under a year.
Debates and open questions
How much the speed owed to mRNA itself, versus massive funding, overlapping trials and earlier spike-protein research by the NIH's Barney Graham and others, is debated.
▸DNA sequencing decoded, within days, the virus targeted by mRNA vaccinesWell documented
The connection
On January 10–11, 2020, Chinese scientists led by Zhang Yongzhen posted the new coronavirus's genetic sequence online. Because an mRNA vaccine is written in genetic code, Moderna had a vaccine design within about two days, and BioNTech began work within weeks. The vaccines were authorized in December 2020.
When and how
Shanghai, January 2020, with the sequence posted via Edward Holmes in Sydney; vaccine designs at Moderna in Cambridge, Massachusetts, and BioNTech in Mainz, Germany.
How we know
The posted sequence is time-stamped in public databases; Moderna and NIH records document design dates, and the first trial doses were given on March 16, 2020.
Debates and open questions
Not disputed. An open question is how fast the next vaccine can come: global planners now aim for 100 days from sequence to approved vaccine.